This episode of “Real-World Data After Dark” features Daniel Chancellor, Dr. Madeline Naylor, and Lance Wolkenbrod discussing how integrated real-world data (RWD) is improving patient access to therapies in multiple myeloma. By combining claims, EMR, lab, mortality, and physician note data, Norstella developed clinical profiles that helped identify patients at key disease stages and match them to appropriate therapies faster. The discussion highlights how AI, clinical expertise, and cross-functional collaboration transformed complex healthcare data into actionable insights, ultimately contributing to more than 800 new patient starts and improving treatment decisions and patient outcomes.